ISMP jeers CDRH
This article was originally published in The Gray Sheet
Executive Summary
The Institute for Safe Medication Practices condemns FDA's device center "for its continued failure, despite patient deaths and injuries," to ban "from all health care settings" infusion pumps without free-flow protection. CDRH's inaction on the issue prompts ISMP to include the center on the negative end of its 1998 list of "Cheers and Jeers." Last spring, the organization called on CDRH to withhold approval of pumps lacking a fail-safe mechanism designed to prevent uncontrolled free-flow of intravenous fluids ("The Gray Sheet" May 18, p. 34)
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 9 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.